Global Microbial Fermentation APIs 麻豆原创 Growth 2025-2031

Publication ID:

LPI01255628

Publication Date:

February 4, 2025

Pages:

113

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Microbial Fermentation APIs market size is predicted to grow from US$ 29540 million in 2025 to US$ 32200 million in 2031; it is expected to grow at a CAGR of 1.5% from 2025 to 2031.
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.

Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API"s or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).

Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).
The major players in global Microbial Fermentation APIs market include Merck, Ajinomoto, HGPF, etc. China is the main market, and occupies about 50% of the global market. Antibiotics and Amino Acids are main types, with a share over 60%.
The 鈥淢icrobial Fermentation APIs Industry Forecast鈥� looks at past sales and reviews total world Microbial Fermentation APIs sales in 2024, providing a comprehensive analysis by region and market sector of projected Microbial Fermentation APIs sales for 2025 through 2031. With Microbial Fermentation APIs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbial Fermentation APIs industry.
This Insight Report provides a comprehensive analysis of the global Microbial Fermentation APIs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microbial Fermentation APIs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Microbial Fermentation APIs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbial Fermentation APIs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbial Fermentation APIs.
This report presents a comprehensive overview, market shares, and growth opportunities of Microbial Fermentation APIs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Antibiotics
Amino Acids
Vitamin
Nucleotide
Organic Acid
Alcohol
Biological Products
Hormone
Segmentation by Application:
Hospitals
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Ajinomoto
HGPF
Huaxing
North China Pharmaceutical
Topfond
DSM
Tianyao
CSPC Pharma
Northeast Pharm
Lukang Pharmaceutical
Luwei Pharmaceutical
Jiangshan (DSM)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Microbial Fermentation APIs market?
What factors are driving Microbial Fermentation APIs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Microbial Fermentation APIs market opportunities vary by end market size?
How does Microbial Fermentation APIs break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Microbial Fermentation APIs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Microbial Fermentation APIs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Microbial Fermentation APIs by Country/Region, 2020, 2024 & 2031
2.2 Microbial Fermentation APIs Segment by Type
2.2.1 Antibiotics
2.2.2 Amino Acids
2.2.3 Vitamin
2.2.4 Nucleotide
2.2.5 Organic Acid
2.2.6 Alcohol
2.2.7 Biological Products
2.2.8 Hormone
2.3 Microbial Fermentation APIs Sales by Type
2.3.1 Global Microbial Fermentation APIs Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Microbial Fermentation APIs Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Microbial Fermentation APIs Sale Price by Type (2020-2025)
2.4 Microbial Fermentation APIs Segment by Application
2.4.1 Hospitals
2.4.2 Research & Academic Laboratories
2.4.3 Pharmaceutical & Biotechnology Companies
2.5 Microbial Fermentation APIs Sales by Application
2.5.1 Global Microbial Fermentation APIs Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Microbial Fermentation APIs Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Microbial Fermentation APIs Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Microbial Fermentation APIs Breakdown Data by Company
3.1.1 Global Microbial Fermentation APIs Annual Sales by Company (2020-2025)
3.1.2 Global Microbial Fermentation APIs Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Microbial Fermentation APIs Annual Revenue by Company (2020-2025)
3.2.1 Global Microbial Fermentation APIs Revenue by Company (2020-2025)
3.2.2 Global Microbial Fermentation APIs Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Microbial Fermentation APIs Sale Price by Company
3.4 Key Manufacturers Microbial Fermentation APIs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Microbial Fermentation APIs Product Location Distribution
3.4.2 Players Microbial Fermentation APIs Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Microbial Fermentation APIs by Geographic Region
4.1 World Historic Microbial Fermentation APIs 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Microbial Fermentation APIs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Microbial Fermentation APIs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Microbial Fermentation APIs 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Microbial Fermentation APIs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Microbial Fermentation APIs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Microbial Fermentation APIs Sales Growth
4.4 APAC Microbial Fermentation APIs Sales Growth
4.5 Europe Microbial Fermentation APIs Sales Growth
4.6 Middle East & Africa Microbial Fermentation APIs Sales Growth
5 Americas
5.1 Americas Microbial Fermentation APIs Sales by Country
5.1.1 Americas Microbial Fermentation APIs Sales by Country (2020-2025)
5.1.2 Americas Microbial Fermentation APIs Revenue by Country (2020-2025)
5.2 Americas Microbial Fermentation APIs Sales by Type (2020-2025)
5.3 Americas Microbial Fermentation APIs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microbial Fermentation APIs Sales by Region
6.1.1 APAC Microbial Fermentation APIs Sales by Region (2020-2025)
6.1.2 APAC Microbial Fermentation APIs Revenue by Region (2020-2025)
6.2 APAC Microbial Fermentation APIs Sales by Type (2020-2025)
6.3 APAC Microbial Fermentation APIs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Microbial Fermentation APIs by Country
7.1.1 Europe Microbial Fermentation APIs Sales by Country (2020-2025)
7.1.2 Europe Microbial Fermentation APIs Revenue by Country (2020-2025)
7.2 Europe Microbial Fermentation APIs Sales by Type (2020-2025)
7.3 Europe Microbial Fermentation APIs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Microbial Fermentation APIs by Country
8.1.1 Middle East & Africa Microbial Fermentation APIs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Microbial Fermentation APIs Revenue by Country (2020-2025)
8.2 Middle East & Africa Microbial Fermentation APIs Sales by Type (2020-2025)
8.3 Middle East & Africa Microbial Fermentation APIs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Microbial Fermentation APIs
10.3 Manufacturing Process Analysis of Microbial Fermentation APIs
10.4 Industry Chain Structure of Microbial Fermentation APIs
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Microbial Fermentation APIs Distributors
11.3 Microbial Fermentation APIs Customer
12 World Forecast Review for Microbial Fermentation APIs by Geographic Region
12.1 Global Microbial Fermentation APIs 麻豆原创 Size Forecast by Region
12.1.1 Global Microbial Fermentation APIs Forecast by Region (2026-2031)
12.1.2 Global Microbial Fermentation APIs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Microbial Fermentation APIs Forecast by Type (2026-2031)
12.7 Global Microbial Fermentation APIs Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Microbial Fermentation APIs Product Portfolios and Specifications
13.1.3 Merck Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Ajinomoto
13.2.1 Ajinomoto Company Information
13.2.2 Ajinomoto Microbial Fermentation APIs Product Portfolios and Specifications
13.2.3 Ajinomoto Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Ajinomoto Main Business Overview
13.2.5 Ajinomoto Latest Developments
13.3 HGPF
13.3.1 HGPF Company Information
13.3.2 HGPF Microbial Fermentation APIs Product Portfolios and Specifications
13.3.3 HGPF Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 HGPF Main Business Overview
13.3.5 HGPF Latest Developments
13.4 Huaxing
13.4.1 Huaxing Company Information
13.4.2 Huaxing Microbial Fermentation APIs Product Portfolios and Specifications
13.4.3 Huaxing Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Huaxing Main Business Overview
13.4.5 Huaxing Latest Developments
13.5 North China Pharmaceutical
13.5.1 North China Pharmaceutical Company Information
13.5.2 North China Pharmaceutical Microbial Fermentation APIs Product Portfolios and Specifications
13.5.3 North China Pharmaceutical Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 North China Pharmaceutical Main Business Overview
13.5.5 North China Pharmaceutical Latest Developments
13.6 Topfond
13.6.1 Topfond Company Information
13.6.2 Topfond Microbial Fermentation APIs Product Portfolios and Specifications
13.6.3 Topfond Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Topfond Main Business Overview
13.6.5 Topfond Latest Developments
13.7 DSM
13.7.1 DSM Company Information
13.7.2 DSM Microbial Fermentation APIs Product Portfolios and Specifications
13.7.3 DSM Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 DSM Main Business Overview
13.7.5 DSM Latest Developments
13.8 Tianyao
13.8.1 Tianyao Company Information
13.8.2 Tianyao Microbial Fermentation APIs Product Portfolios and Specifications
13.8.3 Tianyao Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Tianyao Main Business Overview
13.8.5 Tianyao Latest Developments
13.9 CSPC Pharma
13.9.1 CSPC Pharma Company Information
13.9.2 CSPC Pharma Microbial Fermentation APIs Product Portfolios and Specifications
13.9.3 CSPC Pharma Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 CSPC Pharma Main Business Overview
13.9.5 CSPC Pharma Latest Developments
13.10 Northeast Pharm
13.10.1 Northeast Pharm Company Information
13.10.2 Northeast Pharm Microbial Fermentation APIs Product Portfolios and Specifications
13.10.3 Northeast Pharm Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Northeast Pharm Main Business Overview
13.10.5 Northeast Pharm Latest Developments
13.11 Lukang Pharmaceutical
13.11.1 Lukang Pharmaceutical Company Information
13.11.2 Lukang Pharmaceutical Microbial Fermentation APIs Product Portfolios and Specifications
13.11.3 Lukang Pharmaceutical Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lukang Pharmaceutical Main Business Overview
13.11.5 Lukang Pharmaceutical Latest Developments
13.12 Luwei Pharmaceutical
13.12.1 Luwei Pharmaceutical Company Information
13.12.2 Luwei Pharmaceutical Microbial Fermentation APIs Product Portfolios and Specifications
13.12.3 Luwei Pharmaceutical Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Luwei Pharmaceutical Main Business Overview
13.12.5 Luwei Pharmaceutical Latest Developments
13.13 Jiangshan (DSM)
13.13.1 Jiangshan (DSM) Company Information
13.13.2 Jiangshan (DSM) Microbial Fermentation APIs Product Portfolios and Specifications
13.13.3 Jiangshan (DSM) Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Jiangshan (DSM) Main Business Overview
13.13.5 Jiangshan (DSM) Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.